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Background: Patients (pts) with unoperated single ventricle (SV) physiology rarely survive into adulthood with good functional status and 
may develop Eisenmenger syndrome (ES). We report survival and outcomes of a 30 year cohort of such pts.
methods:  Adult pts with unoperated SV were captured from the Mayo Clinic echocardiographic database from 1984 - 2014. Clinical data 
were obtained by clinic visits, chart review and surveys. Variables between pts with pulmonary stenosis (PS) and ES were compared.
results:  Characteristics of PS versus ES pts are shown (Table). A total of 24 pts were identified; 22 had left ventricular morphology. The 
50 year survival was 75% and 66% pts with PS and ES respectively. There was similar peak age between groups, with the oldest ES 
pt living into the 8th decade of life. Pulmonary vasodilator therapy was used in 72% of pts with ES. Pts with ES had higher incidence of 
hemoptysis; only 1 pt with PS had a stroke secondary to atrial fibrillation. Three with PS needed transplant at 40, 42, and 48 years; 1 had 
right ventricular morphology. Atrial arrhythmias were common (46% in PS; 45% in ES) and 3 pts with ES were able to tolerate epicardial 
pacing systems.
Conclusion:  Selected pts with unoperated SV with PS and balanced physiology can survive with good functional class to the 7th decade 
with good medical management. Strikingly, those pts with ES had similar survival, were effectively managed with pulmonary vasodilator 
therapy, and tolerated epicardial pacing, but had higher rates of stroke and hemoptysis.
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Clinical data
Male 10 4 NS
Single ventricle type
 LV 12 10 NS
 RV 1 1 NS
Peak age at last follow-up/death 55 (30 - 67) 51 (31 - 77) NS
50-year survival 9/12 (75%) 6/9 (66%) NS
NYHA Class 
 I/II 10 6 NS
 III/IV 3 5 NS
Pulmonary vasodilators 0 8 0.0001
 Prostacyclin analogue 0 4 0.03
 PGE1 inhibitors 0 4 0.03
 Endothelin antagonist 0 1 NS
 Combination therapy 0 2 NS
Complications 13 21 NS
 Atrial arrhythmias 6 5 NS
 Stroke 1 5 0.06
 Hemoptysis 0 5 0.01
 Complete heart block 3 2 NS
 Need for epicardial pacing 3 3 NS
Hemodynamic and imaging data
 Hgb (g/dL) 19 ± 2 20 ± 2 NS
 SaO2 (%) 87 ± 4 81 ± 7 NS
 EF (%) 57 (35 - 60) 55 ± 7 (40 - 64) NS
AV regurgitation grade
 Trivial 9 7 NS
 Mild 4 3 NS
 Moderate 1 0 NS
 Severe 0 1 NS
PS, pulmonary stenosis; LV, left ventricle; RV, right ventricle; PGE1, prostaglandin E1; Hgb, hemoglobin; EF, ejection fraction; AV, atrioventricular
